An intranasal adjuvanted, recombinant influenza A/H5 vaccine candidate induces broad priming against diverse influenza A/H5N1 virus clades in a phase I randomized trial in healthy adults
Meagan E Deming, Franklin R Toapanta, Marcela Pasetti, Hana Golding, Surender Khurana, Tarek Hamouda, Ali Fattom, Yuanyuan Liang, Sharon M Tennant, Megan F McGilvray, Paula J Bernal, Jennifer J Oshinsky, Shrimati Datta, Jasnehta Permala Booth, Lynda Coughlan, Kathleen M Neuzil, Chad D Costley, Karen L Kotloff , Marcelo B Sztein, Justin R Ortiz
PMCID: PMC11908355 PMID: 40092447